Genetically modified immune cells may be capable of finding and destroying blood cancer cells, according to the results of a small clinical trial. The study, published in Science Translational Medicine, was conducted on five patients with acute lymphoblastic leukemia. T-cells were extracted from the patients, genetically engineered and reinjected into their bodies. The immune cells quickly eradicated the disease. Scientists say the next step is to conduct multi-center clinical trials before the immunotherapy could be introduced to the mainstream.
Study: Modified immune cells can fight leukemia
SmartBrief Job Listings for Education
|Technical Assistance Associate (8330)||
American Institute for Researcher
|Technical Assistance Consultant (8336)||
|Director of Professional Services||
Engaging Schools, Inc.
|Principal at Timberland Charter Academy||
Timberland Charter Academy
|VP - Partnership Operations||
|Silver Spring, MD|